• About
  • Subscribe
  • Advertise
  • Contact
Friday, March 13, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Company updates & acquisitions

George & Matilda network nears 100-practice milestone  

by Myles Hume
March 20, 2020
in Business, Company updates & acquisitions, Local, News
Reading Time: 2 mins read
A A
Mr Barry Meyerson, of Meyer Optica, is one of the latest to join the network.

Mr Barry Meyerson, of Meyer Optica, is one of the latest to join the network.

Share on FacebookShare on Twitter

George & Matilda Eyecare (G&M) has announced the signing of its 92nd practice, making it the third largest optometry group in Australia since launching in 2016.

Recent additions to the group of independent optometrists include Barry Meyerson, of Meyer Optica in Balmain, New South Wales, and Kirsty Banfield of Mount Martha Optical in Victoria.

The announcement comes on the back of G&M winning the Consumer Goods Growth Company of the Year award in November, a feat it also achieved in 2018, at the Australian Growth Company Awards.

G&M CEO Mr Chris Beer said the group has secured funding and supportive investors to accelerate further acquisitions.

“It is no secret that our model is fully-funded, and we have the ability to scale quickly,” Beer said.

“If you are an independent practice who is looking to retain your uniqueness and focus on your patients, but also have some peace of mind at a time of such turmoil in the economy, then we believe we offer a very compelling opportunity.

“As the fastest growing optometry community in Australia we are proud to be attracting the brightest and the best talent in the country,” he said.

Amid uncertain times, Beer said G&M is bolstering its offering with a focus on flexibility for their practice partners.

“We recognise that everyone who joins George & Matilda is different and has a different set of motivations for why they join. While the principals of our partnerships remain the same, the way we execute varies every single time. This flexibility and willingness to accommodate what makes our practices special is a key ingredient in our success,” he said.

Beer said the business is constantly building on its platforms to ensure it is delivering high value to its practices.

“Our data driven-marketing platforms, coupled with our supply-chain technology and back office support are helping to give back more time to our practice staff and deliver significant growth,” he said.

“In times of uncertainty it is always reassuring to know you have people in your corner fighting with you. We are very proud to be supporting the independent optometry community in these turbulent times and have significant resources at our disposal to help not just our practices, but the communities they serve weather those storms.”

Tags: George & Matilda Eyecaregrowthindependentpractice

Related Posts

Bausch + Lomb’s new enVista Aspire intermediate-optimised IOL. Image: B+L.

Intermediate-optimised IOL bringing patient success

by Rob Mitchell
March 13, 2026

An ophthalmologist in New Zealand was the first in the Southern Hemisphere to try Bausch + Lomb’s new enVista Aspire...

Dr Michele Ginocchietti. Image: EssilorLuxottica

Global executive appointed to lead EssilorLuxottica in ANZ

by Staff Writer
March 12, 2026

Dr Michele Ginocchietti has been appointed head of ANZ at EssilorLuxottica, bringing more than a decade of experience within the...

55.2% of children wearing Abiliti 1-Day showed no clinically meaningful myopia progression* over three years.^1. Image: J &J Vision.

Putting compliance first – new data for ACUVUE Abiliti 1‑Day reinforces efficacy, wearability

by Staff Writer
March 12, 2026

Johnson & Johnson Vision (J&J Vision) says the myopia conversation in optometry practice has shifted from “if” to “when” and...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited